Aviya Lanis

Aviya Lanis


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2022 in Rheumatology
Verified
Journal Article
Closed access
PDF file
ALAviya Lanis
Aviya Lanis
SBSadie Van Den Bogaerde
Sadie Van Den Bogaerde
YZYongdong Zhao
Yongdong Zhao
Aviya Lanis, Sadie Van Den Bogaerde, Yongdong Zhao; Chronic recurrent multifocal osteomyelitis and tofacitinib: a case series, Rheumatology, , keac461, https://

21 November 2023 in JAAD Case Reports
Verified
Journal Article
Open access
ALAviya Lanis
Aviya Lanis
HKHanna Kim
Hanna Kim
SLShajia Lu
Shajia Lu
WTWanxia Li Tsai
Wanxia Li Tsai
AKAmy Kaneshiro
Amy Kaneshiro
SSSusan Shenoi
Susan Shenoi

20 April 2022 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
ALAviya Lanis
Aviya Lanis
RVRita Volochayev
Rita Volochayev
DKDavid E. Kleiner
David E. Kleiner
AVAnusha Vittal
Anusha Vittal
THTheo Heller
Theo Heller
SSSusan Shenoi
Susan Shenoi
Background: We present two cases of Nodular Regenerative Hyperplasia (NRH) associated with Juvenile Dermatomyositis (JDM). Case Presentation: Case 1: A nine-year-old Caucasian male with refractory JDM and anti-NXP2 autoantibodies was diagnosed at age two. Over seven years, he developed arthritis, dysphagia, dysphonia, severe calcinosis, and colitis. Complications included recurrent cellulitis, infections, and hepatosplenomegaly. Multiple medications were chronically used, including prednisone, methotrexate, azathioprine, cyclophosphamide, mycophenolate mofetil, rituximab, tacrolimus, etanercept, abatacept, infliximab, and tocilizumab. Case 2: A 19-year-old Asian female with chronically active JDM and anti-MDA5 autoantibodies was diagnosed at age 15. Symptomatology included ulcerative skin lesions, Raynaud’s phenomenon with digital ulcers, arthritis, interstitial lung disease with pulmonary hypertension, and calcinosis. Medications included chronic use of prednisone, methotrexate, abatacept, cyclophosphamide, mycophenolate mofetil, rituximab, tofacitinib, and sildenafil. In both patients, clinical symptomatology was not suggestive of liver disease or portal hypertension, but laboratory studies revealed elevated serum transaminases with progressive thrombocytopenia and no active liver-associated infections. The first patient’s liver ultrasound showed coarse hepatic texture with mild echogenicity, splenomegaly, and portal hypertension. The second patient’s liver ultrasound was normal, but elastography indicated increased stiffness. Liver biopsy confirmed NRH in both patients. Conclusions: It is difficult to recognize NRH in JDM, as it often presents with elevated transaminases which may be mistaken for JDM muscle flare, corticosteroid-related fatty liver, or medication-related transaminitis. NRH has been associated with several medications used to treat JDM, including methotrexate, azathioprine, and cyclophosphamide, which should be discontinued if NRH develops. Providers should consider NRH in JDM patients with severe, refractory disease who have persistently elevated transaminases and persistent thrombocytopenia.

9 October 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
ALAviya Lanis
Aviya Lanis
ETEmilee Tu
Emilee Tu
MPMalki Peskin
Malki Peskin
MMMaryann Melendez
Maryann Melendez
GTGabriel Tarshish
Gabriel Tarshish
DWDawn Wahezi
Dawn Wahezi
Background: Narrative medicine allows patients to reconstruct medical experiences through written portrayals of perspectives, building a mutual depiction of illness while creating a sense of belonging. This modality has not been previously studied in youth with rheumatologic illnesses, a population with high mental health burden and worse health-related quality of life. We aimed to assess the feasibility of a storytelling intervention in this patient population. Methods: This is a mixed-methods study of 14–21-year-olds with rheumatologic diseases followed in the Bronx, NY. Participants completed an hour-long creative writing session focused on patient experience with chronic disease. Pre- and post-questionnaires assessed patient-reported outcomes, and post-participation video interviews assessed personal experiences through the storytelling session. Results: Thirteen female patients were divided amongst four creative writing sessions. Twelve patients completed pre-study questionnaires and 10 completed post-study questionnaires, with 100% completion of the post-participation interviews. PedsQL surveys showed statistically significant improvement in physical health (p < 0.02), and there was no significant difference between pre- and post-scores for any other questionnaires. Interview thematic domains included writing motivation, prior writing experience, illness experience, relating to others, relationship with providers, and support. Conclusion: Creative writing is a feasible and acceptable intervention for youth with rheumatologic illnesses.

14 March 2024 in Clinical and Experimental Rheumatology
Verified
Journal Article
Closed access
ALAviya Lanis
Aviya Lanis
HAHelene Alexanderson
Helene Alexanderson
KAKaveh Ardalan
Kaveh Ardalan
SESuzanne Edison
Suzanne Edison
CGChristopher D. Graham
Christopher D. Graham
LSLesley Ann Saketkoo
Lesley Ann Saketkoo
Reviews; Authors: A. Lanis, H. Alexanderson, K. Ardalan, S. Edison, C.D. Graham, I. De Groot, L. Gupta, S. Kim, A.M. Knight, L. Kobert, P. Livermore, C. Lood, C. Pilkington, M. Regardt, T.B. Rubinstein, S. Shenoi, L. Turnier, N.B. Voet, D.M. Wahezi, L.A. Saketkoo

19 July 2025 in Clinical Pediatrics
Verified
Journal Article
Closed access
SKSusan Kim
Susan Kim
ALAviya Lanis
Aviya Lanis
QGQi Gao
Qi Gao
JCJaeun Choi
Jaeun Choi
LDLynn F. Davidson
Lynn F. Davidson
Newborns who do not pass hearing screening in the newborn nursery should undergo oto-acoustic emissions (OAE) testing before 1 month with confirmatory auditory brainstem response (ABR) before 3 months. This study investigates caregiver adherence rates to OAE and ABR testing in newborns who were referred for hearing screening in an inner-city urban population, with the aim of identifying risk factors for poor adherence. A retrospective chart review of full-term infants in 2016 and 2019 at 2 Bronx hospitals found nearly one third of newborns did receive the recommended 1-month OAE, and half of those referred following OAE missed timely 3-month ABR testing. Combining data from both years, multivariable analysis found maternal spoken language as a significant variable affecting ABR adherence. This study suggests future interventions should target language barriers to increase adherence rates for timely newborn hearing screening.